Inicio / Hematología / Abstracts de hematología / Development and validation…

Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry

0 / 5 (0 votos)
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry

The Lancet Haematology

Fecha de publicación: Marzo de 2021

DOI: https://doi.org/10.1016/S2352-3026(20)30394-X

Autores: Roni Shouval, MD *, Joshua A Fein, MD *, Myriam Labopin, MD, Christina Cho, MD,Prof Ali Bazarbachi, MD, Frédéric Baron, MD,Gesine Bug, MD, Prof Fabio Ciceri, MD, Prof Selim Corbacioglu, MD,Jacques-Emmanuel Galimard, PhD,Prof Sebastian Giebel, MD, Maria H Gilleece, MD, Prof Sergio Giralt, MD, Prof Ann Jakubowski, MD, Silvia Montoto, MD, Prof Richard J O’Reilly, MD, Prof Esperanza B Papadopoulos, MD, Zinaida Peric, MD, Annalisa Ruggeri, MD,Jaime Sanz, MD,Craig S Sauter, MD, Prof Bipin N Savani, MD,Prof Christoph Schmid, MD, Prof Alexandros Spyridonidis, MD,Roni Tamari, MD, Jurjen Versluis, MD,Prof Ibrahim Yakoub-Agha, MD,Miguel Angel Perales, MD, Prof Mohamad Mohty, MD , Prof Arnon Nagler, MD 

Background: Diagnosis and remission status at the time of allogeneic haematopoietic stem-cell transplantation (HSCT) are the principal determinants of overall survival following transplantation. We sought to develop a contemporary disease-risk stratification system (DRSS) that accounts for heterogeneous transplantation indications.

Leer más

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.